Cardinal Health Inc (CAH) : Foyston Gordon Payne Inc reduced its stake in Cardinal Health Inc by 0.32% during the most recent quarter end. The investment management company now holds a total of 100,031 shares of Cardinal Health Inc which is valued at $8,362,592 after selling 322 shares in Cardinal Health Inc , the firm said in a disclosure report filed with the SEC on Aug 11, 2016.Cardinal Health Inc makes up approximately 1.47% of Foyston Gordon Payne Inc’s portfolio.
Other Hedge Funds, Including , Wfg Advisors Lp boosted its stake in CAH in the latest quarter, The investment management firm added 375 additional shares and now holds a total of 387 shares of Cardinal Health Inc which is valued at $32,353. Cardinal Health Inc makes up approx 0.01% of Wfg Advisors Lp’s portfolio.Eaton Vance Management boosted its stake in CAH in the latest quarter, The investment management firm added 24,772 additional shares and now holds a total of 287,918 shares of Cardinal Health Inc which is valued at $24,072,824. Cardinal Health Inc makes up approx 0.07% of Eaton Vance Management’s portfolio.Central Trust Co reduced its stake in CAH by selling 873 shares or 14.33% in the most recent quarter. The Hedge Fund company now holds 5,221 shares of CAH which is valued at $436,528. Cardinal Health Inc makes up approx 0.03% of Central Trust Co’s portfolio.Meeder Asset Management Inc reduced its stake in CAH by selling 9,410 shares or 59.26% in the most recent quarter. The Hedge Fund company now holds 6,470 shares of CAH which is valued at $536,945. Cardinal Health Inc makes up approx 0.05% of Meeder Asset Management Inc’s portfolio.Kanaly Trust Co reduced its stake in CAH by selling 116 shares or 22.22% in the most recent quarter. The Hedge Fund company now holds 406 shares of CAH which is valued at $33,694. Cardinal Health Inc makes up approx 0.01% of Kanaly Trust Co’s portfolio.
Cardinal Health Inc closed down -0.13 points or -0.16% at $82.02 with 8,99,566 shares getting traded on Tuesday. Post opening the session at $82.39, the shares hit an intraday low of $82 and an intraday high of $82.56 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Investors should note that on Aug 8, 2016, Cardinal Health Inc announced a cash dividend of $0.4489. The company’s management has announced Sep 29, 2016 as the ex-dividend date and fixed the record date on Oct 3, 2016. The payable date has been fixed on Oct 15, 2016.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.